MILWAUKEE, March 13, 2024 – ConsortiEX, an industry leader in compliance and patient-safety focused software and services for outsourcing and hospital pharmacies, is pleased to announce a new strategic partnership with LedgerDomain, a pioneering identity and secure messaging platform tailored for modern decentralized[...]
Milwaukee, WI – The FDA recently issued updated guidance for industry surrounding DSCSA and the upcoming requirement deadline. Passed in 2013, DSCSA aims to reduce counterfeit and illegitimate products from reaching dispensers, improving patient outcomes and securing the pharmacy supply chain. The 10-year rollout was[...]
ConsortiEX is exhibiting at this year’s ASHP Summer Meeting in Baltimore, MD, from June 10-14! You can find us at Booth 615.
The ConsortiEX Customer Spotlight series has historically been used to highlight the impact that the Assure-Trak® Compounding Management System has had on improving compliance documentation and workflow efficiency initiatives at both 503B Outsourcing Facilities and Health System pharmacies, showing the real-world[...]
2023 marks a very special year for ConsortiEX, as we celebrate our 10th year of operations, and our 10th year of providing innovative service and solutions to the pharmacy community. Follow along each month as we recant our evolution from a small start-up into an industry leading DQSA Compliance Provider.
The FDA recently updated the FDA to Compounders: Know Your Bulks and Excipients Suppliers page, which now includes links to guidance documents, examples of past quality issues, and a log of FDA actions against trading partners for violations of Good Manufacturing Practice Requirements (GMP).
The FDA recently issued guidance on the definition of Suspect and Illegitimate Products, set forth in the Federal Food Drug and Cosmetic Act1. This guidance aims to assist trading partners in putting systems in place to identify and handle suspect and illegitimate products, meeting Drug Supply Chain Security Act[...]
